Article
DLL3 regulates Notch signaling in small cell lung cancer
16 Nov 2022
Abstract excerpt
Tumor heterogeneity plays a critical role in tumor development and response to treatment. In small-cell lung cancer (SCLC), intratumoral heterogeneity is driven in part by the Notch signaling pathway, which reprograms neuroendocrine cancer cells to a less/non-neuroendocrine state. Here we investigated the atypical Notch ligand DLL3 as a biomarker of the neuroendocrine state and a regulator of cell-cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
